
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Nobuko Kobayashi is a partner in global management consulting firm A.T. Kearney’s Consumer Goods and Retail Practice, serving Japanese and multinational clients in consumer industries.

Published: May 14th 2018 | Updated:

Published: July 9th 2018 | Updated: